Semaglutide for the Reduction of Arrhythmia Burden in Overweight AF Patients

Clinical trial NCT04885634 · WITHDRAWN

Trial details

NCT number: NCT04885634
Sponsor: Axel Brandes
Status: WITHDRAWN
Phase: Phase 3
Study type: INTERVENTIONAL

Atrial Fibrillation Overweight and Obesity

Start date: 2022-10-01
Primary completion: 2024-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.